BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: López-Martin A, Ballestín C, Garcia-Carbonero R, Castaño A, Lopez-Ríos F, López-Encuentra A, Sánchez-Cespedes M, Castellano D, Bartolomé A, Cortés-Funes H, Paz-Ares L. Prognostic value of KIT expression in small cell lung cancer. Lung Cancer 2007;56:405-13. [PMID: 17420067 DOI: 10.1016/j.lungcan.2007.01.029] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Terada T. Primary esophageal small cell carcinoma with brain metastasis and with CD56, KIT, and PDGFRA expressions. Pathol Oncol Res. 2012;18:1091-1093. [PMID: 21626441 DOI: 10.1007/s12253-011-9374-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
2 Terada T. Esophageal small cell carcinoma without neuroendocrine features but with KIT and PDGFRA expression: KIT as a useful marker of this type of tumor. J Gastrointest Cancer 2014;45 Suppl 1:132-5. [PMID: 24604264 DOI: 10.1007/s12029-014-9595-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Cameselle-teijeiro JM, Mato Mato JA, Fernández Calvo O, García Mata J. Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis—Prognostic and Predictive Factors. Mol Diagn Ther 2018;22:169-77. [DOI: 10.1007/s40291-018-0315-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Yokouchi H, Nishihara H, Harada T, Ishida T, Yamazaki S, Kikuchi H, Oizumi S, Uramoto H, Tanaka F, Harada M, Akie K, Sugaya F, Fujita Y, Takamura K, Kojima T, Higuchi M, Honjo O, Minami Y, Watanabe N, Goto A, Suzuki H, Dosaka-Akita H, Isobe H, Nishimura M, Munakata M. Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker. Oncotarget 2017;8:39711-26. [PMID: 28055980 DOI: 10.18632/oncotarget.14410] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
5 Terada T, Maruo H. Esophageal combined carcinomas: Immunohoistochemical and molecular genetic studies. World J Gastroenterol 2012; 18(13): 1545-1551 [PMID: 22509088 DOI: 10.3748/wjg.v18.i13.1545] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
6 Terada T. Primary small cell carcinoma of the mediastinum: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol 2009;26:247-50. [PMID: 18989797 DOI: 10.1007/s12032-008-9116-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
7 Terada T. Autopsy case of primary small cell carcinoma of the urinary bladder: KIT and PDGFRA expression and mutations. Pathol Int 2009;59:247-50. [PMID: 19351368 DOI: 10.1111/j.1440-1827.2009.02358.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
8 Huh WK, Sill MW, Darcy KM, Elias KM, Hoffman JS, Boggess JF, Alvarez RD, Long HJ, O'malley DM, Birrer MJ. Efficacy and safety of imatinib mesylate (Gleevec®) and immunohistochemical expression of c-Kit and PDGFR-β in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus. Gynecologic Oncology 2010;117:248-54. [DOI: 10.1016/j.ygyno.2010.01.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
9 Swarts DR, Ramaekers FC, Speel EJ. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Biochim Biophys Acta 2012;1826:255-71. [PMID: 22579738 DOI: 10.1016/j.bbcan.2012.05.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 65] [Article Influence: 2.4] [Reference Citation Analysis]
10 Cheng Y, Li H, Ma L, Zhang S, Yan S, Zhu J, Wang S, Zhang R, Niu K, Liu Y. Detection of c-kit mutational status in small-cell lung cancer in a Chinese cohort. Thorac Cancer 2014;5:225-31. [PMID: 26767005 DOI: 10.1111/1759-7714.12082] [Reference Citation Analysis]
11 Eliyakin N, Postaci H, Baskin Y, Kozacioğlu Z. Small Cell Carcinoma of the Urinary Bladder: KIT and PDGFRA Gene Mutations. Rare Tumors 2015;7:5982. [PMID: 26788274 DOI: 10.4081/rt.2015.5982] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
12 Ross JS, Wang K, Elkadi OR, Tarasen A, Foulke L, Sheehan CE, Otto GA, Palmer G, Yelensky R, Lipson D, Chmielecki J, Ali SM, Elvin J, Morosini D, Miller VA, Stephens PJ. Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer. J Clin Pathol 2014;67:772-6. [PMID: 24978188 DOI: 10.1136/jclinpath-2014-202447] [Cited by in Crossref: 52] [Cited by in F6Publishing: 61] [Article Influence: 6.5] [Reference Citation Analysis]
13 Marech I, Gadaleta CD, Ranieri G. Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma. Int J Mol Sci. 2014;15:13060-13076. [PMID: 25056544 DOI: 10.3390/ijms150713060] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
14 Terada T. KIT-positive primary small cell carcinoma of the endometrium: a case report with immunohistochemical and molecular genetic analysis of KIT and PDGFRA genes. Arch Gynecol Obstet 2010;282:413-6. [PMID: 20035340 DOI: 10.1007/s00404-009-1324-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
15 Yuan T, Sun S, Cao Z, Feng X, Gao Y. Prognostic immunohistochemical markers for small cell lung cancer: A review. Pathol Res Pract 2021;217:153311. [PMID: 33310282 DOI: 10.1016/j.prp.2020.153311] [Reference Citation Analysis]
16 Terada T. Primary small cell carcinoma of the ureter: a case report involving immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Pathology 2010;42:101-2. [PMID: 20025496 DOI: 10.3109/00313020903443018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
17 Xiao H, Wang J, Liu Y, Li L. Relative influence of c-Kit expression and epidermal growth factor receptor gene amplification on survival in patients with non-small cell lung cancer. Oncol Lett 2014;8:582-8. [PMID: 25013472 DOI: 10.3892/ol.2014.2173] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
18 Tong B, Zhao J, Wang M. [Advances on Driver Mutations of Small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi 2016;19:236-40. [PMID: 27118653 DOI: 10.3779/j.issn.1009-3419.2016.04.10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Salomonsson A, Jönsson M, Isaksson S, Karlsson A, Jönsson P, Gaber A, Bendahl PO, Johansson L, Brunnström H, Jirström K, Borg Å, Staaf J, Planck M. Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma. Genes Chromosomes Cancer 2013;52:1088-96. [PMID: 24019021 DOI: 10.1002/gcc.22103] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
20 Terada T. Small cell neuroendocrine carcinoma of the prostate: incidence and a report of four cases with an examination of KIT and PDGFRA. Prostate 2012;72:1150-6. [PMID: 22127977 DOI: 10.1002/pros.22464] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
21 Marech I, Patruno R, Zizzo N, Gadaleta C, Introna M, Zito AF, Gadaleta CD, Ranieri G. Masitinib (AB1010), from canine tumor model to human clinical development: where we are? Crit Rev Oncol Hematol. 2014;91:98-111. [PMID: 24405856 DOI: 10.1016/j.critrevonc.2013.12.011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
22 Hernandez RK, Adhia A, Wade SW, O'Connor E, Arellano J, Francis K, Alvrtsyan H, Million RP, Liede A. Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States. Clin Epidemiol 2015;7:335-45. [PMID: 26229504 DOI: 10.2147/CLEP.S85496] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
23 Holden JA, Willmore-Payne C, Layfield LJ. Gastrointestinal Stromal Tumors: A Guide to the Diagnosis. Surg Pathol Clin 2010;3:241-76. [PMID: 26839131 DOI: 10.1016/j.path.2010.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Terada T. Primary small cell carcinoma of the pleura: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol 2010;27:1119-22. [PMID: 19859843 DOI: 10.1007/s12032-009-9345-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
25 Pros E, Lantuejoul S, Sanchez-Verde L, Castillo SD, Bonastre E, Suarez-Gauthier A, Conde E, Cigudosa JC, Lopez-Rios F, Torres-Lanzas J, Castellví J, Ramon y Cajal S, Brambilla E, Sanchez-Cespedes M. Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer. Int J Cancer 2013;133:898-907. [PMID: 23400671 DOI: 10.1002/ijc.28090] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
26 Matsumura Y, Umemura S, Ishii G, Tsuta K, Matsumoto S, Aokage K, Hishida T, Yoshida J, Ohe Y, Suzuki H, Ochiai A, Goto K, Nagai K, Tsuchihara K. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma. J Cancer Res Clin Oncol 2015;141:2159-70. [PMID: 25989941 DOI: 10.1007/s00432-015-1989-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
27 Patruno R, Marech I, Zizzo N, Ammendola M, Nardulli P, Gadaleta C, Introna M, Capriuolo G, Rubini RA, Ribatti D. c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies. Biomed Res Int. 2014;2014:730246. [PMID: 24900982 DOI: 10.1155/2014/730246] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
28 Mishra A, Mishra SC, Tripathi AM, Pandey A. Clinical correlation of molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) expression in juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol 2018;275:2719-26. [DOI: 10.1007/s00405-018-5110-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]